Regulation of urokinase-type plasminogen activator production by cultured human cytotrophoblasts

J Biol Chem. 1987 Aug 15;262(23):10903-6.

Abstract

Cultured human cytotrophoblasts synthesize and secrete urokinase-type plasminogen activator (uPA) during the first 24 h of culture, but secretion declines during the subsequent day. In contrast, synthesis and secretion of fibronectin increases during the 2 days of culture. The levels of uPA mRNA parallel the changes in synthesis and secretion of uPA. Treatment of cytotrophoblasts with 8-bromo-cAMP (1.5 mM) transiently raises uPA mRNA levels and uPA secretion. This treatment reduces fibronectin mRNA levels and causes a sustained increase in beta chorionic gonadotropin mRNA content and chorionic gonadotropin secretion. We conclude that a cAMP-mediated process up-regulates uPA expression in cytotrophoblasts. However, the stimulatory effect of the cyclic nucleotide analog on uPA is transient.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • 8-Bromo Cyclic Adenosine Monophosphate / pharmacology
  • Cells, Cultured
  • Fibronectins / biosynthesis
  • Fibronectins / metabolism
  • Immunosorbent Techniques
  • Kinetics
  • RNA, Messenger / metabolism
  • Trophoblasts / drug effects
  • Trophoblasts / enzymology*
  • Urokinase-Type Plasminogen Activator / biosynthesis*
  • Urokinase-Type Plasminogen Activator / metabolism

Substances

  • Fibronectins
  • RNA, Messenger
  • 8-Bromo Cyclic Adenosine Monophosphate
  • Urokinase-Type Plasminogen Activator